NCT00719693View on ClinicalTrials.gov

Assessment of the Effect of Food on ABT-143 Bioavailability

PHASE1CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

September 30, 2008

Conditions
Pharmacokinetic Variables
Interventions
DRUG

ABT-143 ( rosuvastatin calcium and fenofibric acid )

one dose under low-fat meal condition

DRUG

ABT-143 (rosuvastatin calcium and fenofibric acid )

one dose under fasting meal condition

Trial Locations (1)

47710

Site Reference ID/Investigator# 9242, Evansville

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY